Ian Karp
Public Communications Contact at INTELLIA THERAPEUTICS, INC.
Ian Karp active positions
Companies | Position | Start | End |
---|---|---|---|
INTELLIA THERAPEUTICS, INC. | Public Communications Contact | - | - |
Career history of Ian Karp
Former positions of Ian Karp
Companies | Position | Start | End |
---|---|---|---|
SHIRE | Investor Relations Contact | 2016-02-29 | 2017-11-30 |
Corporate Officer/Principal | 2011-12-31 | 2015-12-31 | |
Medimmune, Inc. | Sales & Marketing | - | - |
KARYOPHARM THERAPEUTICS INC. | Investor Relations Contact | 2018-07-24 | - |
Public Communications Contact | 2018-07-24 | - |
Training of Ian Karp
Emory University | Undergraduate Degree |
Rutgers Business School | Masters Business Admin |
Statistics
International
United States | 6 |
Ireland | 2 |
Operational
Investor Relations Contact | 2 |
Public Communications Contact | 2 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
INTELLIA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Medimmune, Inc. | Health Technology |
- Stock Market
- Insiders
- Ian Karp
- Experience